INTERACTION OF HUMAN CHAGASIC IGG WITH THE 2ND EXTRACELLULAR LOOP OF THE HUMAN HEART MUSCARINIC ACETYLCHOLINE-RECEPTOR - FUNCTIONAL AND PATHOLOGICAL IMPLICATIONS
Jc. Goin et al., INTERACTION OF HUMAN CHAGASIC IGG WITH THE 2ND EXTRACELLULAR LOOP OF THE HUMAN HEART MUSCARINIC ACETYLCHOLINE-RECEPTOR - FUNCTIONAL AND PATHOLOGICAL IMPLICATIONS, The FASEB journal, 11(1), 1997, pp. 77-83
Circulating antibodies from human and murine chagasic sera are able to
interact with myocardium-activating neurotransmitter receptors, Here
we reported the presence of autoantibodies against the second extracel
lular loop of the human heart muscarinic acetylcholine receptors (nACh
R) in patients with Chagas' disease by using a synthetic 24-mer peptid
e in immunoblotting and enzyme immunoassay, Affinity-purified antipept
ide IgG from chagasic patients, similar to monoclonal antihuman M(2) m
AChR, recognized bands with a molecular weight corresponding to the ca
rdiac mAChR. The binding was inhibited by the peptide, assessing the s
pecificity of the interaction, The antipeptide autoantibody also displ
ayed an ''agonist-like'' activity modifying the intracellular events a
ssociated with mAChR activation, i.e., decreased contractility, increa
sed cGMP, and decreased cAMP production, All of these effects on rat a
tria by chagasic antipeptide autoantibodies resemble the effects of th
e authentic agonist and those of the total polyclonal chagasic IgG, be
ing selectively blunted by atropine and neutralized by the synthetic p
eptide corresponding in aminoacid sequence to the second extracellular
loop of the human Mp mAChR. A clinical relevance of these findings is
demonstrated by a strong association between the existence of circula
ting antipeptide antoantibodies in chagasic patients and the presence
of dysautonomic symptoms, making these antoantibodies a proper early m
arker of heart autonomic dysfunction.